Loading patent…
AssigneeThe Regents of the University of California
InventorsThomas J. Kipps, Sanjai Sharma, Mark Cantwell
Estimating the term…
This invention relates to genes which encode accessory molecule ligands, such as the CD40 ligand and their use for immunomodulation, vaccination and treatments of various human diseases, including malignancies and autoimmune diseases. This invention also describes the use of accessory molecule ligands which are made up of various domains and subdomain portions of molecules derived from the tumor necrosis factor family. The chimeric molecules of this invention contain unique properties which lead to the stabilization of their activities and thus greater usefulness in the treatment of diseases. Vectors for expressing genes which encode the accessory molecule ligands of this invention are also disclosed.
A method for expressing a chimeric CD40 ligand in a CD40+ human cell, wherein the chimeric CD40 ligand includes one or more human CD40 ligand domains and one or more mouse CD40 ligand domains the method comprising introducing a chimeric polynucleotide a chimeric polynucleotide encoding the chimeric CD40 ligand into the cell.
Dependencies are inferred from the claim text.